Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 50,000,000
    Countries
    Sector(s)
    Italy : € 50,000,000
    Services : € 50,000,000
    Signature date(s)
    22/07/2011 : € 10,000,000
    17/06/2008 : € 20,000,000
    23/06/2008 : € 20,000,000

    Summary sheet

    Release date
    14 February 2005
    Status
    Reference
    Signed | 17/06/2008
    20040346
    Project name
    Promoter - financial intermediary
    CNAO Cancer Treatement Centre Pavia
    A private law foundation created by public authorities in 2001 for the purpose of developing a national centre for hadrontherapy. The founders include two large research and health care institutes , two oncological hospitals, the Italian National Neurological Institute and a private scientific foundation.

    Contact point: Dott. Sandro Rossi
    Phone : 02.6448.5410

    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    Approximately EUR 60 million
    Approximately EUR 130 million
    Location
    Sector(s)
    Description
    Objectives

    Construction near Pavia (N. Italy) of a new cancer treatment structure offering highly specialist services based on radiation therapy, proton therapy and carbon ion therapy, an advanced clinical research centre and ancillary facilities.

    Treatment of specific types of cancer located in soft/deep tissues through sophisticated innovative nuclear applications known as "hadrontherapy".

    Environmental aspects
    Procurement

    EU Directive 97/11/EC does not specifically mention hospital activities on Environmental Impact Assessment (EIA). As the project includes elements of construction in urban settings it might be construed as an Annex II development. The basis for whether an EIA has been requested by the competent authorities or not, local planning and approval process and actual/possible significant impacts on protected flora and fauna (Habitats and Birds Directives) will be verified during project appraisal.

    Promoter's procurement procedures will be verified during appraisal.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications